Two months after Pfizer’s covid vaccine was authorized for children ages 5 to 11, just 27% have received at least one shot, according to Jan. 12 data from the Centers for Disease Control and Prevention. Only 18%, or 5 million kids, have both doses.
Moderna's authorized booster (50 µg) increased Omicron neutralizing antibody levels approximately 37-fold, while a 100 µg booster increased these levels approximately 83-fold.
The CDC has expanded its recommendations for the COVID-19 vaccine booster to all Americans age 16 and older.
New research shows patients with inflammatory bowel disease (IBD) produced a strong antibody response to COVID-19 vaccination.
Read More
Researchers say that most people who think they will have an allergic reaction, or who believe they have had an allergic response to the first vaccine, can safely be fully vaccinated.
Read More
Participants in a CDC study were over five times more likely to have COVID-19 if they were unvaccinated and had a prior infection compared to those who were vaccinated without previous infection.
Read More
Many Americans now have the green light to get a COVID-19 vaccine booster – and the flexibility to receive a different brand than the original vaccine they received.
Read More
For children 5-11, the Pfizer-BioNTech COVID-19 vaccine is administered as a two-dose primary series, 3 weeks apart, but in a lower dose (10 μg).
Read More
An FDA vaccine advisory committee voted 17 to 0 to recommend the emergency use of the Pfizer/BioNTech COVID-19 vaccine in children 5 to <12 years of age.
Read More
Novavax has completed its rolling regulatory submission for authorization of its NVX-CoV2373 COVID-19 vaccine candidate in the United Kingdom.
Read More
Researchers analyzed the association between state vaccination rates and the subsequent COVID-19 cases and deaths in each state.
Read MoreTwo 50 μg doses of Moderna’s vaccine mRNA-1273 was generally well tolerated in children ages 6-11, who generated antibody levels 1.5 times greater than young adults in the study.
Read More
The French pharmaceutical company Valneva announced positive topline results from the Phase 3 trial for its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.
Read More
The FDA authorized single booster doses for the Moderna Inc and Janssen COVID-19 vaccines for certain adults age 18 and older, as well as the use of “mix and match” boosters of differing vaccines.
Read More
Healthcare organizations strongly urge individuals to get vaccinated against the COVID-19 virus and to receive their influenza (flu) immunizations for the upcoming flu season.
Read More